Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (621-630 of 977) with videos related to

Pageof 98
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 21, 2025
Results of an international survey on the management of therapeutic intensity unfractionated heparin: communication from the SSCs of the ISTHIsabelle Gouin-Thibault, Lana A Castellucci, Jean M Connors, et al.
Leukemia & Lymphoma|March 23, 2002
Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classificationJ Diebold, J R Anderson, J O Armitage, et al.
Haematologica|February 13, 2009
CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failureNathalie A Johnson, Stephen Leach, Bruce Woolcock, et al.
Blood|January 25, 2007
Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community settingLaurie H Sehn, Jane Donaldson, Allison Filewich, et al.
Plos One|February 21, 2012
Genetic variation in cell death genes and risk of non-Hodgkin lymphomaJohanna M Schuetz, Denise Daley, Jinko Graham, et al.
Haematologica|October 3, 2009
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOPJesse Shustik, Guangming Han, Pedro Farinha, et al.
Anesthesia and Analgesia|September 1, 1995
Initial clinical experience with remifentanil, a new opioid metabolized by esterasesM Dershwitz, G I Randel, C E Rosow, et al.
Alternative Therapies in Health and Medicine|February 7, 2008
Increasing research capacity at the New England School of Acupuncture: building grants management infrastructurePeter M Wayne, Lawrence M Pensack, Ellen M Connors, et al.
British Journal of Haematology|December 11, 2019
Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphomaAnna R Hayden, Derrick G Lee, Diego Villa, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 9, 2022
D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent ValidationJoseph R Bledsoe, Daniel Knox, Ithan D Peltan, et al.
Pageof 98

Showing results (621-630 of 977) with videos related to

Sort By:
Pageof 98
Journal of Thrombosis and Haemostasis : JTH|February 21, 2025
Results of an international survey on the management of therapeutic intensity unfractionated heparin: communication from the SSCs of the ISTHIsabelle Gouin-Thibault, Lana A Castellucci, Jean M Connors, et al.
Leukemia & Lymphoma|March 23, 2002
Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classificationJ Diebold, J R Anderson, J O Armitage, et al.
Haematologica|February 13, 2009
CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failureNathalie A Johnson, Stephen Leach, Bruce Woolcock, et al.
Blood|January 25, 2007
Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community settingLaurie H Sehn, Jane Donaldson, Allison Filewich, et al.
Plos One|February 21, 2012
Genetic variation in cell death genes and risk of non-Hodgkin lymphomaJohanna M Schuetz, Denise Daley, Jinko Graham, et al.
Haematologica|October 3, 2009
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOPJesse Shustik, Guangming Han, Pedro Farinha, et al.
Anesthesia and Analgesia|September 1, 1995
Initial clinical experience with remifentanil, a new opioid metabolized by esterasesM Dershwitz, G I Randel, C E Rosow, et al.
Alternative Therapies in Health and Medicine|February 7, 2008
Increasing research capacity at the New England School of Acupuncture: building grants management infrastructurePeter M Wayne, Lawrence M Pensack, Ellen M Connors, et al.
British Journal of Haematology|December 11, 2019
Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphomaAnna R Hayden, Derrick G Lee, Diego Villa, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 9, 2022
D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent ValidationJoseph R Bledsoe, Daniel Knox, Ithan D Peltan, et al.
Pageof 98